Loading data
CPHINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.14 m USD | 4.53 m USD | 7.01 m USD | 8.1 m USD | 9.64 m USD |
| Cost of revenue | 4.28 m USD | 6.51 m USD | 7.29 m USD | 8.6 m USD | 9.29 m USD |
| Gross profit | -131.95 k USD | -1.99 m USD | -281.09 k USD | -493.92 k USD | 349.27 k USD |
| Research and development expense | 280.9 k USD | 283.94 k USD | 240.08 k USD | 185.86 k USD | 318.96 k USD |
| Operating profit | -3.24 m USD | -4.59 m USD | -2.75 m USD | -3.55 m USD | -2.86 m USD |
| Interest expense | 27.27 k USD | 27.35 k USD | 30.57 k USD | 434.62 k USD | 542 k USD |
| Profit before tax | -3.19 m USD | -4.74 m USD | -3.08 m USD | -3.97 m USD | -3.4 m USD |
| Net income (reported basis) | -3.19 m USD | -4.74 m USD | -3.08 m USD | -3.97 m USD | -3.4 m USD |
| Basic earnings per share | -0.74 USD/share | -2.71 USD/share | -0.91 USD/share | -3.78 USD/share | -0.74 USD/share |
| Diluted earnings per share | -0.74 USD/share | -2.71 USD/share | -0.91 USD/share | -3.78 USD/share | -0.74 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.